Back to Search
ROBERT NICHOLSON, MD
MD
Specialist
NPI: 1124417373IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
016664(LA)
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Class of 1982
Research & Publications (20)
Unintended effects of emphasizing disparities in cancer communication to African-Americans.
PMID 18990735·Cancer Epidemiol Biomarkers Prev·2008
2-rct
ERPs dissociate the effects of switching task sets and task cues.
PMID 16714004·Brain Res·2006
4-observational
Components of task-set reconfiguration: differential effects of 'switch-to' and 'switch-away' cues.
PMID 17010947·Brain Res·2006
8-other
Electrophysiological correlates of anticipatory task-switching processes.
PMID 16176376·Psychophysiology·2005
8-other
Anesthetic-like interaction of the sleep-inducing lipid oleamide with voltage-gated sodium channels in mammalian brain.
PMID 11135731·Anesthesiology·2001
7-preclinical
Indices of lactate threshold and their relationship with 10-km running velocity.
PMID 11224827·Med Sci Sports Exerc·2001
4-observational
Phemx, a novel mouse gene expressed in hematopoietic cells maps to the imprinted cluster on distal chromosome 7.
PMID 10950922·Genomics·2000
7-preclinical
The quality of forensic psychological assessments, reports, and testimony: acknowledging the gap between promise and practice.
PMID 10693317·Law Hum Behav·2000
6-review
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
PMID 19238537·Breast Cancer Res Treat·2010
8-other
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.
PMID 19288272·Breast Cancer Res Treat·2010
8-other
MyD88 and TRIF mediate the cyclic adenosine monophosphate (cAMP) induced corticotropin releasing hormone (CRH) expression in JEG3 choriocarcinoma cell line.
PMID 19615077·Reprod Biol Endocrinol·2009
8-other
Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells.
PMID 19330798·J Cell Biochem·2009
8-other
Doubly diastereoselective conjugate addition of homochiral lithium amides to homochiral alpha,beta-unsaturated esters containing cis- and trans-dioxolane units.
PMID 19194592·Org Biomol Chem·2009
8-other
Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells.
PMID 18493848·Breast Cancer Res Treat·2009
8-other
Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation.
PMID 19246244·Trends Mol Med·2009
8-other
Control of microbial contamination of Franz diffusion cell receptor phase in the development of transcutaneous breast cancer therapeutics.
PMID 19674294·Lett Appl Microbiol·2009
7-preclinical
Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.
PMID 18825690·J Pathol·2009
8-other
Doubly diastereoselective [3,3]-sigmatropic aza-Claisen rearrangements.
PMID 19503936·Org Biomol Chem·2009
8-other
SRC as a therapeutic target in breast cancer.
PMID 19075780·Endocr Metab Immune Disord Drug Targets·2008
6-review
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
PMID 19074892·Cancer Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 42078 VETERANS AVENUE, SUITE G
HAMMOND, LA 70403 - Phone
- (985) 542-7177
Quick Facts
- NPI
- 1124417373
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile